Buy Aurobindo Pharma; target of Rs 850: Axis Direct News News / News 6 years ago 548 Views comments Axis Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 850 in its research report dated July 24,... Read more
News Reliance Capital arm to get Rs 300 cr loan from IREDA for green projects News / News - 6 years ago
News India to dispatch 350 Indian soldiers, warships and aircraft for major tri-service exercise with Russia News / News - 6 years ago
Comments